Yahoo Finance Thermo Fisher Scientific (TMO) Exceeds Market Returns: Some Facts to Consider
In the latest market close, Thermo Fisher Scientific (TMO) reached $579.37, with a +1.85% movement compared to the previous day. The stock's performance was ahead of the S&P 500's daily gain of 0.86%. On the other hand, the Dow registered a gain of 1.22%, and the technology-centric Nasdaq increased by 0.51%.
Prior to today's trading, shares of the maker of scientific instrument and laboratory supplies had gained 0.47% over the past month. This has outpaced the Medical sector's loss of 0.63% and lagged the S&P 500's gain of 2.84% in that time.
Market participants will be closely following the financial results of Thermo Fisher Scientific in its upcoming release. The company is predicted to post an EPS of $4.71, indicating a 6.36% decline compared to the equivalent quarter last year. Our most recent consensus estimate is calling for quarterly revenue of $10.14 billion, down 5.28% from the year-ago period.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $21.53 per share and a revenue of $42.74 billion, indicating changes of -0.09% and -0.28%, respectively, from the former year.
Any recent changes to analyst estimates for Thermo Fisher Scientific should also be noted by investors. These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. Thermo Fisher Scientific is currently a Zacks Rank #3 (Hold).
Looking at its valuation, Thermo Fisher Scientific is holding a Forward P/E ratio of 26.43. This signifies no noticeable deviation in comparison to the average Forward P/E of 26.43 for its industry.
It is also worth noting that TMO currently has a PEG ratio of 2.39. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Medical - Instruments was holding an average PEG ratio of 2.39 at yesterday's closing price.
The Medical - Instruments industry is part of the Medical sector. This group has a Zacks Industry Rank of 66, putting it in the top 27% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Thermo Fisher Scientific Inc. (TMO) : Free Stock Analysis Report
